Novel Strategies in the Design and Production of Vaccines

Hardcover | February 29, 1996

EditorSara Cohen, Avigdor Shafferman

not yet rated|write a review
The proceedings of the conference held in May 1995 reflect the current research findings in vaccine development, particularly in response to new viruses and to those that have developed resistances. The presentations provide strategies in recombinant DNA technology and immunogencity enhancement of subunit vaccines; new approaches in bacterial vaccines; the latest HIV vaccine strategies; and reports on adjuvants and delivery systems, as well as production processes and clinical evaluations. Annotation c. by Book News, Inc., Portland, Or.

Pricing and Purchase Info

$340.85 online
$375.95 list price (save 9%)
In stock online
Ships free on orders over $25

From the Publisher

The proceedings of the conference held in May 1995 reflect the current research findings in vaccine development, particularly in response to new viruses and to those that have developed resistances. The presentations provide strategies in recombinant DNA technology and immunogencity enhancement of subunit vaccines; new approaches in ba...

Format:HardcoverDimensions:214 pages, 10 × 7.01 × 0.03 inPublished:February 29, 1996Publisher:Springer US

The following ISBNs are associated with this title:

ISBN - 10:0306452111

ISBN - 13:9780306452116

Look for similar items by category:

Customer Reviews of Novel Strategies in the Design and Production of Vaccines

Reviews

Extra Content

Table of Contents

Recombinant Antigens and Presentation Vectors: Synthetic Vaccines for Infectious and Autoimmune Diseases M. Sela Host Range Restricted, Nonreplicating Vaccinia Virus Vectors as Vaccine Candidates; B. Moss, et al. Hybrid Hepatitis B Virus Core Antigen as a Vaccine Carrier Moiety II: Expression in Avirueltn Salmonell spp. for Mucosal Immunization; F. Schödel, et al. Synthetic Recombinant Vaccine Induces Antiinfluenza Longterm Immunity and Crossstrain Protection; R. Arnon, R. Levy Alphaviurs-based Expression Systems; C.M. Rice Alphavirus Hybrid Virion Vaccines; A. Shafferman, et al. DNA Vaccines for Bacteria and Viruses; J.B. Ulmer, et al. Bacterial Vaccines: Novel Approaches: New Vaccines against Bacterial Toxins; R. Rappuoli, et al. Parameters for the Rational Design of Genetic Toxoid Vaccines; W.N. Burnette Protective Immunity Induced by Bacillus anthracis Toxin Mutant Strains; C. Pezard, et al. Bacterial Outer Membrane Protein Vaccines: The Meningococall Example; J.T. Poolman Strategies for HIV Vaccine: Changing Paradigms for an HIV Vaccine; A.M. Schultz Complexed HIV Envelope as a Target for an AIDS Vaccine; J.M. Gershoni, et al. HIVPeplotion Vaccine: A Novel Approach to Vaccination against AIDS by Transepithelial Transport of Viral Peptides and Antigens to Langerhans Cells for Induction of Cytolytic T Cells by HLA Class I and CD1 Molecules for Long Term Protection; Y. Becker Adjuvants and Delivery Systems: The Role of Adjuvants and Delivery Systems in Modulation of Immune Response to Vaccines; R.K. Gupta, et al. Unique Immunomodulating Properties of Dimethyl Dioctadecyl Ammonium Bromide (DDA) in Experimental Virus Vaccines; D. Katz, et al. Production Processes and Clinical Evaluation: Challenges in the Development of Combination Vaccines; R.W. Ellis Polysaccharide Conjugate Vaccines for the Prevention of Grampositive Bacterial Infections; R. Naso, A. Fattom Production of Influenza Virus in Cell Cultures for Vaccine Preparation; O.W. Merten, et al. Analysis of Bordetella pertussis Suspensions by ELISA and Flow Cytometry; W. Jiskoot, et al. Clinical Trials of Shigella Vaccines in Israel; D. Cohen, et al. Vaccine Development: General Consideration: Hypothesis: How Licensed Vaccines Confer Protective Immunity; J.B. Robbins, et al. Therapeutic Vaccines: A Pandoric Prospect; R.E. Spier Index.